- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
Breast Cancer: Fall in Annual Incidence
SAN ANTONIO -- The annual incidence of breast cancer has fallen drastically, coinciding with the end of the hormone replacement therapy era, according to SEER data from the National Cancer Institute. After a steady rise during the past 20 years, the incidence dropped 7% from 2002 to 2003, reported investigators at the San Antonio Breast Cancer Symposium. The absolute reduction could be as many as 14,000 breast cancer cases per year.
SAN ANTONIO, Dec. 14 -- The annual incidence of breast cancer has fallen drastically, coinciding with the end of the hormone replacement therapy era, according to SEER data from the National Cancer Institute. After a steady rise during the past 20 years, the incidence dropped 7% from 2002 to 2003, reported investigators at the San Antonio Breast Cancer Symposium. The absolute reduction could be as many as 14,000 breast cancer cases per year.
Phase 3 Data Support Oral Orforglipron for Weight Maintenance After GLP-1–Based Weight Loss
December 19th 2025Topline Phase 3 ATTAIN-MAINTAIN data show oral orforglipron met primary and key secondary endpoints for weight maintenance after prior GLP-1–based injectable therapy in adults with obesity.
